The novel small-molecule antagonist MMG-11 preferentially inhibits TLR2/1 signaling
Authors:
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 171, 113687
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (DFG RA 895/16-1)
This publication has 53 references indexed in Scilit:
- Lipid moieties on lipoproteins of commensal and non-commensal staphylococci induce differential immune responsesNature Communications, 2017
- Toll-Like Receptor Pathways in Autoimmune DiseasesClinical Reviews in Allergy & Immunology, 2015
- The Role of TLR2 in Infection and ImmunityFrontiers in Immunology, 2012
- Structural Biology of the Toll-Like Receptor FamilyAnnual Review of Biochemistry, 2011
- Pathogen recognition in the innate immune responseBiochemical Journal, 2009
- Membrane Sorting of Toll-like Receptor (TLR)-2/6 and TLR2/1 Heterodimers at the Cell Surface Determines Heterotypic Associations with CD36 and Intracellular TargetingJournal of Biological Chemistry, 2006
- How Toll-like receptors signal: what we know and what we don’t knowCurrent Opinion in Immunology, 2006
- Toll-like receptor signallingNature Reviews Immunology, 2004
- Innate Immune RecognitionAnnual Review of Immunology, 2002
- The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptorsProceedings of the National Academy of Sciences, 2000